Rosenblatt raised the firm’s price target on Elastic (ESTC) to $130 from $120 and keeps a Buy rating on the shares. The firm expects the stock ...

Cyclosporin H boosts a new lentivirus-delivered gene therapy with enhanced anti-sickling properties in blood stem cells from ...

For organizations using vector databases to store text and associated embeddings containing sensitive data for use by their GenAI application, they can now run vector database operations, like ...

Every IPO S-1 prospectus includes a section listing all kinds risk factors for why its stock may not be a good buy. With ...